Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 22.36
1.36 %
$ 1.03 B
Market Cap
-11.29
P/E
Price Target
Average
28.95%
Revenue Forecast
Estimate
4.93%
EBIT
Estimate
0.73%
Net Income
Estimate
77.14%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Pacira BioSciences, Inc.
Wall Street analysts predict an average 1-year price target for PCRX of $28.8 , with forecasts ranging from
a
low of
$8 to a high of $57 .
PCRX Lowest Price Target
Wall Street Target
8 USD
-64.22%
PCRX Average Price Target
Wall Street Target
28.8 USD
28.95%
PCRX Highest Price Target
Wall Street Target
57 USD
154.92%
REVENUE FORECAST
Revenue Forecast Chart PCRX
EBIT FORECAST
EBIT Forecast Chart PCRX
NET INCOME FORECAST
Net Income Chart PCRX